Universe Pharmaceuticals (UPC) Finished Goods (2021 - 2025)

Universe Pharmaceuticals has disclosed Finished Goods across 5 years of filings, most recently posting $1.6 billion for Q3 2025.

• Finished Goods for Q3 2025 came in at $1.6 billion, up 40.91% year-over-year; the trailing twelve-month figure through Sep 2025 was $1.6 billion (up 40.91% YoY), and the FY2025 annual result was $1.6 billion, up 40.91% from the prior year.
• Finished Goods came in at $1.6 billion for Q3 2025 at Universe Pharmaceuticals, up from $1.1 billion in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $1.6 billion in Q3 2025 to a low of $1.3 million in Q3 2022.
• The 5-year median for Finished Goods is $2.8 million (2023), against an average of $551.2 million.
• Across the five-year window, Finished Goods tumbled 32.14% in 2022 and soared 40997.28% in 2024, its largest moves.
• Universe Pharmaceuticals' Finished Goods stood at $2.0 million in 2021, then tumbled by 32.14% to $1.3 million in 2022, then soared by 107.64% to $2.8 million in 2023, then jumped by 40997.28% to $1.1 billion in 2024, then jumped by 40.91% to $1.6 billion in 2025.
• The last three Finished Goods figures came in at $1.6 billion (Q3 2025), $1.1 billion (Q3 2024), and $2.8 million (Q3 2023), per Business Quant data.